Showing results (171-180 of 271) with videos related to
Sort By:
Pageof 28
Journal of Surgical Oncology|May 4, 2018
Vein resection during pancreaticoduodenectomy for pancreatic adenocarcinoma: Patency rates and outcomes associated with thrombosisRebecca A Snyder, Laura R Prakash, Graciela M Nogueras-Gonzalez, et al.Journal of Medicinal Chemistry|December 2, 2022
Development of SOS1 Inhibitor-Based Degraders to Target <i>KRAS</i>-Mutant Colorectal CancerYujia Bian, Diego Alem, Francisca Beato, et al.The Oncologist|March 11, 2022
BRAF Mutations Are Associated with Poor Survival Outcomes in Advanced-stage Mismatch Repair-deficient/Microsatellite High Colorectal CancerElaine Tan, Junmin Whiting, Hao Xie, et al.Journal of Behavioral Medicine|August 20, 2022
Patient-caregiver dyads in pancreatic cancer: identification of patient and caregiver factors associated with caregiver well-beingBrent T Xia, Amy K Otto, Kelvin Allenson, et al.Plos One|December 3, 2014
Metastatic recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) nude mouse model is inhibited by neoadjuvant chemotherapy in combination with fluorescence-guided surgery with an anti-CA 19-9-conjugated fluorophoreYukihiko Hiroshima, Ali Maawy, Yong Zhang, et al.Annals of Diagnostic Pathology|November 5, 2011
Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosisQing Zhao, Asif Rashid, Yun Gong, et al.American Journal of Clinical Oncology|March 23, 2022
Core Homologous Recombination Mutations and Improved Survival in Nonpancreatic GI CancersElaine Tan, Junmin Whiting, Todd Knepper, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|October 17, 2013
Morbidity and mortality after pancreaticoduodenectomy in patients with borderline resectable type C clinical classificationChing-Wei D Tzeng, Matthew H G Katz, Jason B Fleming, et al.Histopathology|May 7, 2015
The number and ratio of positive lymph nodes affect pancreatic cancer patient survival after neoadjuvant therapy and pancreaticoduodenectomyLaurice K Fischer, Matthew H Katz, Sun M Lee, et al.Annals of Surgical Oncology|February 15, 2013
Frequency and intensity of postoperative surveillance after curative treatment of pancreatic cancer: a cost-effectiveness analysisChing-Wei D Tzeng, Daniel E Abbott, Scott B Cantor, et al.Pageof 28